Hi
We are conducting a pragmatic pop-pk study following a single
extravascular dose of an opioid in children. The parent molecule is
rapidly hydrolysed to metabolite 1, which is subsequently hydrolysed to
metabolite 2. Metabolite 2 is metabolised to metabolite 3 and 4, but
also partially renally excreted. The plasma is being bioanalysed for
metabolite 1 to 4, but not the parent (latter has a half-life of 2-3
mins, and is not known to contribute significantly to PD). Typically, we
are managing to get between 3- 4 samples per subject and hope to recruit
approx. 75 children.
We are part way through the study and have done an interim bioanalysis.
I have two model development questions as I plan my analysis:-
1. Since parent is not being measured, how would you parameterise
the formation of metabolite 1? i.e. since the appearance of metabolite 1
is a 'two-step' process, absorption of drug and subsequent hydrolysis,
would you consider using previous literature reported estimates of
absorption rate to estimate formation clearance of metabolite 1, or is
it more sensible to estimate the composite parameter (absorption +
formation clearance)?
2. It is clear from the interim bioanalysis, that we are not
sampling our far enough to observe the elimination phase of metabolite 3
and 4 i.e. I'm only seeing accumulation. This is a pragmatic hospital
study so it is unlikely that I can persuade the clinicians / nurses /
patients to generate later samples. With that in mind is there any
mileage in including metabolite 3 and 4 in the model?
Regards
Hussain
Hussain Mulla
Senior Research Pharmacist
Department of Pharmacy
University Hospitals of Leicester NHS Trust
Glenfield Hospital
Groby Road
Leicester
LE3 9QP
Tel: 0116 2502708
This e-mail, including any attached files, may contain confidential and / or
privileged information and is intended for the exclusive use of the
addressee(s) printed above. If you are not the addressee(s), any unauthorised
review, disclosure, reproduction, other dissemination or use of this e-mail, or
taking of any action in reliance upon the information contained herein, is
strictly prohibited. If this e-mail has been sent to you in error, please
return to the sender. No guarantee can be given that the contents of this email
are virus free - The University Hospitals of Leicester NHS Trust cannot be held
responsible for any failure by the recipient(s) to test for viruses before
opening any attachments. The information contained in this e-mail may be the
subject of public disclosure under the Freedom of Information Act 2000 - unless
legally exempt from disclosure, the confidentiality of this e-mail and your
reply cannot be guaranteed. Copyright in this email and any attachments created
by us remains vested in the University Hospitals of Leicester NHS Trust.